Literature DB >> 5488219

Observations on the treatment of rheumatoid disease with penicillamine.

J R Golding, J V Wilson, A T Day.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5488219      PMCID： PMC2466784          DOI： 10.1136/pgmj.46.540.599

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  PYRIDOXINE DEFICIENCY IN THE RAT PRODUCED BY D-PENICILLAMINE.

Authors:  A M ASATOOR
Journal:  Nature       Date:  1964-09-26       Impact factor: 49.962

2.  THE ANTIPYRIDOXINE EFFECT OF PENICILLAMINE IN MAN.

Authors:  I A JAFFE; K ALTMAN; P MERRYMAN
Journal:  J Clin Invest       Date:  1964-10       Impact factor: 14.808

3.  Dissociation of human serum macroglobulins.

Authors:  H F DEUTSCH; J I MORTON
Journal:  Science       Date:  1957-03-29       Impact factor: 47.728

4.  Decreased taste sensitivity after D-penicillamine reversed by copper administration.

Authors:  R I Henkin; H R Keiser; I A Jafee; I Sternlieb; I H Scheinberg
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321

5.  The effect of penicillamine on the laboratory parameters in rheumatoid arthritis.

Authors:  I A Jaffe
Journal:  Arthritis Rheum       Date:  1965-12
  5 in total
  11 in total

1.  Rheumatoid arthritis treated with small doses of penicillamine.

Authors:  J R Golding; A T Day; M R Tomlinson; R M Brown; M O Hassan; S R Langstaff
Journal:  Proc R Soc Med       Date:  1977

2.  Effect of penicillamine on the kidney.

Authors:  A M Davison; A T Day; J R Golding; D Thomson
Journal:  Proc R Soc Med       Date:  1977

3.  Reaction to D-penicillamine in rheumatoid arthritis.

Authors:  A T Day; J R Golding
Journal:  Br Med J       Date:  1973-09-15

4.  Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor.

Authors:  R Bluestone; L S Goldberg
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

5.  Penicillamine in the treatment of rheumatoid arthritis.

Authors:  E C Huskisson; F D Hart
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

Review 6.  Red cell aplasia following prolonged D-penicillamine therapy.

Authors:  J L Gollan; S Hussein; A V Hoffbrand; S Sherlock
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

7.  Penicillamine: its place in rheumatology.

Authors: 
Journal:  Br Med J       Date:  1978-01-21

8.  Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis.

Authors:  M H Pritchard; G Nuki
Journal:  Ann Rheum Dis       Date:  1978-12       Impact factor: 19.103

9.  Experimental murine amyloidosis II: effect of penicillamine therapy.

Authors:  A Savage; C Hinton; C R Tribe
Journal:  Br J Exp Pathol       Date:  1980-10

10.  Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.

Authors:  A J Dixon; J Davies; T L Dormandy; E B Hamilton; P J Holt; R M Mason; M Thompson; J C Weber; D W Zutshi
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.